|18.28||+0.4800||+2.70%||Vol 246.98K||1Y Perf 136.52%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||24.80||Analyst Rating||Moderate Buy 1.80|
|Potential %||35.67||Finscreener Ranking||★★★★ 53.85|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★+ 53.46|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 54.00|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||745.31M||Earnings Rating||Sell|
|Price Range Ratio 52W %||70.45||Earnings Date||5th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||5th May 2021|
|Estimated EPS Next Report||-0.20|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||205.17K|
|Avg. Monthly Volume||184.77K|
|Avg. Quarterly Volume||234.88K|
Axogen Inc. (NASDAQ: AXGN) stock closed at 18.28 per share at the end of the most recent trading day (a 2.7% change compared to the prior day closing price) with a volume of 258.58K shares and market capitalization of 745.31M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 394 people. Axogen Inc. CEO is Karen Zaderej.
The one-year performance of Axogen Inc. stock is 136.52%, while year-to-date (YTD) performance is 2.12%. AXGN stock has a five-year performance of 234.8%. Its 52-week range is between 7.29 and 22.89, which gives AXGN stock a 52-week price range ratio of 70.45%
Axogen Inc. currently has a PE ratio of -31.40, a price-to-book (PB) ratio of 6.24, a price-to-sale (PS) ratio of 8.24, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -12.87%, a ROC of -15.50% and a ROE of -17.82%. The company’s profit margin is -17.22%, its EBITDA margin is -17.20%, and its revenue ttm is $88.04 Million , which makes it $2.16 revenue per share.
Of the last four earnings reports from Axogen Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Axogen Inc.’s next earnings report date is 05th May 2021.
The consensus rating of Wall Street analysts for Axogen Inc. is Moderate Buy (1.8), with a target price of $24.8, which is +35.67% compared to the current price. The earnings rating for Axogen Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Axogen Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Axogen Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.16, ATR14 : 1.20, CCI20 : -232.76, Chaikin Money Flow : -0.11, MACD : -0.21, Money Flow Index : 35.53, ROC : -12.14, RSI : 38.68, STOCH (14,3) : 16.21, STOCH RSI : 0.00, UO : 43.20, Williams %R : -83.79), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Axogen Inc. in the last 12-months were: Angelo Scopelianos (Sold 1 134 shares of value $20 197 ), Erick Wayne DeVinney (Option Excercise at a value of $72 833), Erick Wayne DeVinney (Sold 518 shares of value $9 021 ), Gregory G. Freitag (Option Excercise at a value of $970 758), Gregory G. Freitag (Sold 26 590 shares of value $574 514 ), Isabelle Billet (Sold 649 shares of value $11 559 ), Karen Zaderej (Option Excercise at a value of $219 809), Karen Zaderej (Sold 83 775 shares of value $1 586 691 ), Maria D. Martinez (Sold 567 shares of value $10 098 ), Mark Louis Friedman (Option Excercise at a value of $29 405), Mark Louis Friedman (Sold 1 326 shares of value $23 349 ), Michael Patrick Donovan (Option Excercise at a value of $165 200), Michael Patrick Donovan (Sold 22 100 shares of value $345 642 ), Peter J. Mariani (Option Excercise at a value of $302 400), Peter J. Mariani (Sold 77 457 shares of value $970 279 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.